We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Human Clinical Specimens Available For In Vitro Diagnostics Development and Production

By LabMedica International staff writers
Posted on 24 Apr 2012
A new source of high quality clinical specimens, compliant with all regulatory and quality standards guidelines, has now been made available for various in vitro diagnostics (IVD) development and production uses. More...


In addition to its clinical and research-based products for the in vitro diagnostics and life sciences industries, Binding Site (San Diego, CA, USA) now also provides these specimens. The clinical specimens can be provided in a variety of different matrices, which can be further characterized by specific analyte and concentration/titer, along with additional information on age, sex, and disease state. Specimen volumes are available in a variety of configurations ranging from milliliters up to liter volumes, and are offered in a variety of formats (i.e., pooled sera/plasma, single donor, dialyzed serum, etc.). All necessary documentation and paperwork is also supplied.

Availability and sourcing of high quality human clinical specimens to IVD manufacturers and suppliers is vital in ensuring the scientific relevance and validity of clinical instrumentation and reagent applications. In addition, these specimens are also necessary for a host of other critical studies, including new product development work, validation studies, and ongoing technical support projects.

Related Links:

Binding Site



New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Urine Analyzer
respons® UDS100
New
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The method that profiles DNA methylation in cell-free DNA from a single blood sample to detect disease signals system-wide (photo courtesy of Shutterstock)

cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample

Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read more

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more

Pathology

view channel
Image: Spatial characterization of immune–tumor interactions and treatment response across SCLC and extended phenotype models (Cristian Barrera et al, npj Precision Oncology (2026). DOI: 10.1038/s41698-025-01225-9)

AI Pathology Tool Predicts Chemotherapy Response in Small Cell Lung Cancer

Small cell lung cancer often presents at an extensive stage and progresses rapidly, leaving little time to tailor first-line therapy. Clinicians currently lack biomarkers to guide which patients will benefit... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.